Previous 10 | Next 10 |
2023-08-08 07:17:56 ET 908 Devices press release ( NASDAQ: MASS ): Q2 GAAP EPS of -$0.29 beats by $0.06 . Revenue of $12.1M (+9.0% Y/Y) beats by $1.56M . Handheld revenue was $8.8 million, increasing 27% year over year Desktop revenue was $3.1 million, decr...
Revenue increases 9% compared to prior year, driven by handheld revenue growth of 27% 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended June 30, 2023. ...
2023-08-07 13:02:51 ET 908 Devices ( NASDAQ: MASS ) is scheduled to announce Q2 earnings results on Tuesday, August 8th, before market open. The consensus EPS Estimate is -$0.34 (-30.8% Y/Y) and the consensus Revenue Estimate is $10.54M (-5.0% Y/Y).Over the last 1 year, MASS...
908 Devices Inc , (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces that several Tennessee drug task forces, law enforcement agencies and county sheriffs’ offices have chosen to implement the company’s MX908 ...
MX908 Beacon quickly identifies harmful levels of chemical warfare and pharmaceutical-based agents, empowering swift response and remediation 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the...
908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the second quarter 2023 before market open on Tuesday, August 8, 2023. Company management will webcast a corresponding conference ...
2023-07-10 08:56:27 ET Mobilicom ( MOB ) +76% Secures Commercial Scale Purchase Order from U.S. Tier-1 Manufacturer for Initial Production of Drones for the U.S. DOD. Nanobiotix ( NBTX ) +50% up 54% on licensing agreement for development of Radioenhancer ...
2023-06-13 17:41:09 ET Gainers: Inventiva ( IVA ) +42% . NOVONIX ( NVX ) +5% . EyePoint Pharmaceuticals ( EYPT ) +5% . 908 Devices ( MASS ) +5% . Vera Therapeutics ( VERA ) +5% . Losers: Microvision ( MVIS ...
Key oral presentation highlights the company’s prototype microfluidic chips for multi-omics workflows 908 Devices Inc (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, is showcasing its ZipChip CE-MS device for rapi...
908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming William Blair 43 rd Annual Growth Stock Conference. 908 Devices’ management is scheduled to present on Wednesday, Ju...
News, Short Squeeze, Breakout and More Instantly...
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, has appointed Michele M. Leonhart, the former Administrator of the United States Drug Enforcement Administration (DEA), to serve on its Board of Directors effective immediately. Ms....
Updated technology enables first responders to identify and quantify approximately 5,000 substances in mere seconds for a swift and definitive response 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced an ...
2024-06-01 11:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...